A European study performed country-specific, cost-effective analyses of vaccination strategies for human papilloma virus (HPV), taking into account factors such as number of doses and target population. The outcome of the PREHDICT study provides a picture of the effectiveness of vaccination and alerts the general public about HPV-related diseases.
Further information: cordis.europa.eu